US Broker Ratings

Kestra Medical Technologies, Ltd. (KMTS) Investor Outlook: Exploring a Promising 8.65% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a pioneering company in the healthcare sector, is capturing investor attention with its innovative wearable medical devices and digital healthcare solutions...

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with Strong Buy Ratings and 7.12% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention as a promising player in the biotechnology sector, offering innovative treatments for serious diseases. Despite a..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 26.94% Potential Upside in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST), a prominent player in the healthcare sector, specifically in medical care facilities, has been making waves with its comprehensive approach..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring the 55.32% Potential Upside and Analysts’ Strong Buy Ratings

AtriCure, Inc. (NASDAQ: ATRC) stands out in the healthcare sector, particularly within the medical instruments and supplies industry. With a market capitalization of $1.58 billion, AtriCure..

Harrow, Inc. (HROW) Investor Outlook: A Potential 37% Upside in the Eyecare Pharmaceuticals Sector

Harrow, Inc. (HROW), a prominent player in the eyecare pharmaceutical industry, is drawing significant attention from investors, particularly given its promising potential upside of 37%. This..

10x Genomics, Inc. (TXG) Stock Analysis: Navigating Growth Potential in Health Information Services

10x Genomics, Inc. (NASDAQ: TXG) stands as a prominent player in the healthcare sector, particularly within the health information services industry. With a market capitalization of..

Neogen Corporation (NEOG) Stock Analysis: Evaluating Its 5.20% Potential Upside in the Diagnostics & Research Sector

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, has been attracting investor attention due to its recent stock..

Mineralys Therapeutics, Inc. (MLYS) Stock Analysis: A Biotech Gem with 77% Upside Potential

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is capturing the attention of investors with its compelling potential for growth in the biotechnology sector. With a market capitalization of..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Healthcare Innovator with 11% Upside Potential

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a prominent player in the medical devices sector, has captured investor attention with its innovative approach to aesthetic and reconstructive..

Astrana Health Inc. (ASTH) Stock Analysis: A Healthcare Gem with Nearly 80% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH) stands out in the healthcare sector with a compelling investment narrative, driven by its robust revenue growth and promising analyst ratings...

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Target Price Suggests 26.84% Upside for Biotech Innovator

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning player in the biotechnology sector, is attracting significant interest from investors, largely due to its promising pipeline of therapies..

Harmony Biosciences Holdings (HRMY) Stock Analysis: Positioned for a 70% Upside in Biotech Sector

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) is making waves in the biotech industry with its focus on innovative therapies for neurological diseases. Investors seeking promising opportunities..

Kiniksa Pharmaceuticals (KNSA) Stock Analysis: A Biopharma’s Strong Growth Trajectory and 17.9% Upside Potential

Kiniksa Pharmaceuticals International (NASDAQ: KNSA), a biopharmaceutical company specializing in the development and commercialization of treatments for diseases with unmet needs, has captured investor attention with..

Xenon Pharmaceuticals Inc. (XENE) Investor Outlook: Analyzing a 30% Potential Upside with Strong Buy Ratings

Xenon Pharmaceuticals Inc. (XENE), a Canada-based biopharmaceutical company, is garnering attention in the healthcare sector, particularly in biotechnology. Specializing in neuroscience-focused therapeutics, Xenon is making strides..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Significant Upside with a 55.42% Potential

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is capturing investor attention with its compelling growth potential in the biotechnology sector. With a market capitalization of $3.77 billion, this..

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Strong Analyst Buy Ratings and 25.49% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD), a key player in the healthcare sector, specifically within the medical care facilities industry, presents an intriguing investment opportunity for..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 14.60% Potential Upside

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) stands out in the healthcare sector, particularly within the drug manufacturing industry, for its focus on both specialty and generic pharmaceuticals...

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook Highlights 21% Potential Upside

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry, has recently captured the attention of..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Exploring a 213% Potential Upside

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) has captured the attention of the healthcare investment community with its innovative approach to addressing severe allergic reactions. As a biotechnology..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds